Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.
Cross-Recognition of a Myelin Peptide by CD8+ T Cells in the CNS Is Not Sufficient to Promote Neuronal Damage.
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Chronic hepatitis B infection presenting with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report.
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.
A 62-year-old man with fluctuating neurological deficits and skin lesions.
[Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum].
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Clinical impact of early brain atrophy in clinically isolated syndromes.
Errors in the Byline, Author Affiliations, and Author Contributions in: Long-term Follow-up of Acute Partial Transverse Myelitis.
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.
Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
Linked in and up to speed.
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Mining gene expression data of multiple sclerosis.
The fibrotic scar in neurological disorders.
Artificial antigen presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells.
Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.
RP-CARS reveals molecular spatial order anomalies in myelin of an animal model of Krabbe disease.
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
Pages
« first
‹ previous
…
545
546
547
548
549
550
551
552
553
…
next ›
last »